Literature DB >> 28679508

A Scale of Agonism and Allosteric Modulation for Assessment of Selectivity, Bias, and Receptor Mutation.

Terry Kenakin1.   

Abstract

An index of agonism is described that can be used to quantify agonist receptor selectivity, bias, cell-based agonism, and the effects of receptor mutation on signaling. The parameter is derived from agonist concentration-response curves and comprises the maximal response to the agonist (max) and the EC50 in the form of Δlog(max/EC50). This parameter is derived from equations describing agonists as positive allosteric facilitators of receptor-signaling protein interaction. A similar index is also derived to quantify the potentiating effects of positive allosteric modulators, which can be used to quantify in situ positive allosteric modulator activity in vivo. These indices lend themselves to statistical analysis and are system-independent in that the effects of the system processing of agonist response and differences in assay sensitivity and receptor expression are cancelled. The various applications of the Δlog(max/EC50) scale are described for each pharmacologic application.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Mesh:

Substances:

Year:  2017        PMID: 28679508     DOI: 10.1124/mol.117.108787

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  24 in total

1.  Quantitative structural assessment of graded receptor agonism.

Authors:  Jinsai Shang; Richard Brust; Patrick R Griffin; Theodore M Kamenecka; Douglas J Kojetin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

2.  D1 dopamine receptors intrinsic activity and functional selectivity affect working memory in prefrontal cortex.

Authors:  Yang Yang; Sang-Min Lee; Fumiaki Imamura; Krishne Gowda; Shantu Amin; Richard B Mailman
Journal:  Mol Psychiatry       Date:  2018-12-07       Impact factor: 15.992

3.  Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68).

Authors:  Xufen Yu; Xi-Ping Huang; Terry P Kenakin; Samuel T Slocum; Xin Chen; Michael L Martini; Jing Liu; Jian Jin
Journal:  J Med Chem       Date:  2019-08-01       Impact factor: 7.446

4.  The δ-opioid receptor positive allosteric modulator BMS 986187 is a G-protein-biased allosteric agonist.

Authors:  M Alexander Stanczyk; Kathryn E Livingston; Louise Chang; Zara Y Weinberg; Manojkumar A Puthenveedu; John R Traynor
Journal:  Br J Pharmacol       Date:  2019-04-14       Impact factor: 8.739

Review 5.  Neutrophil Signaling That Challenges Dogmata of G Protein-Coupled Receptor Regulated Functions.

Authors:  Claes Dahlgren; André Holdfeldt; Simon Lind; Jonas Mårtensson; Michael Gabl; Lena Björkman; Martina Sundqvist; Huamei Forsman
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-11

6.  GPR124 regulates microtubule assembly, mitotic progression, and glioblastoma cell proliferation.

Authors:  Allison E Cherry; Juan Jesus Vicente; Cong Xu; Richard S Morrison; Shao-En Ong; Linda Wordeman; Nephi Stella
Journal:  Glia       Date:  2019-05-06       Impact factor: 7.452

7.  Differential Roles of Extracellular Histidine Residues of GPR68 for Proton-Sensing and Allosteric Modulation by Divalent Metal Ions.

Authors:  Xi-Ping Huang; Terrence P Kenakin; Shuo Gu; Brian K Shoichet; Bryan L Roth
Journal:  Biochemistry       Date:  2020-09-10       Impact factor: 3.162

8.  A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.

Authors:  Marta Sanchez-Soto; Ravi Kumar Verma; Blair K A Willette; Elizabeth C Gonye; Annah M Moore; Amy E Moritz; Comfort A Boateng; Hideaki Yano; R Benjamin Free; Lei Shi; David R Sibley
Journal:  Sci Signal       Date:  2020-02-04       Impact factor: 8.192

9.  Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine.

Authors:  Shane W Kaski; Allison N White; Joshua D Gross; Kristen R Trexler; Kim Wix; Aubrie A Harland; Thomas E Prisinzano; Jeffrey Aubé; Steven G Kinsey; Terry Kenakin; David P Siderovski; Vincent Setola
Journal:  J Pharmacol Exp Ther       Date:  2019-09-06       Impact factor: 4.030

10.  Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects.

Authors:  Ram Kandasamy; Todd M Hillhouse; Kathryn E Livingston; Kelsey E Kochan; Claire Meurice; Shainnel O Eans; Ming-Hua Li; Andrew D White; Bernard P Roques; Jay P McLaughlin; Susan L Ingram; Neil T Burford; Andrew Alt; John R Traynor
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.